No results for ‘’
Indraprastha Medical Corporation Ltd
₹382.95
(0.83%)
Fri, 26 Jun 2026, 00:57 am
Health Services
Hospital/Nursing Management
24.5KIndraprastha Medical Corporation Price to Sales Ratio (P/S)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 19.73 | 17.64 | 17.67 | 10.71 | 13.38 | 10.15 | 12.02 | 10.43 | 10.04 | 15.71 | 19.46 | 18.55 | 20.98 | 12.37 | 7.13 | 211.53 | 9.14 | 8.27 | 12.70 | 21.98 |
| Price to book ratio | 2.94 | 2.30 | 2.50 | 2.10 | 3.06 | 2.09 | 2.03 | 1.76 | 1.90 | 2.62 | 2.13 | 2.11 | 1.91 | 1.44 | 1.16 | 1.81 | 1.65 | 1.88 | 3.30 | 5.93 |
| Price to sales ratio | 1.61 | 1.12 | 0.91 | 0.65 | 0.98 | 0.72 | 0.64 | 0.50 | 0.54 | 0.73 | 0.63 | 0.65 | 0.60 | 0.45 | 0.38 | 0.80 | 0.60 | 0.65 | 1.26 | 2.61 |
| Price to cash flow ratio | 12.91 | 15.41 | 5.64 | 4.60 | 5.90 | 9.04 | 6.10 | 4.74 | 6.76 | 8.39 | 7.87 | 17.63 | 9.50 | 4.78 | 3.66 | 17.67 | 7.32 | 4.66 | 7.45 | 20.71 |
| Enterprise value | 375Cr | 308Cr | 347Cr | 302Cr | 441Cr | 381Cr | 387Cr | 369Cr | 413Cr | 554Cr | 522Cr | 547Cr | 500Cr | 350Cr | 301Cr | 473Cr | 473Cr | 586Cr | 1384Cr | 3250Cr |
| Enterprise value to EBITDA ratio | 18.99 | 16.21 | 16.58 | 6.47 | 7.38 | 7.55 | 7.96 | 4.92 | 5.41 | 8.22 | 6.60 | 8.02 | 7.51 | 4.78 | 3.82 | 11.32 | 3.92 | 3.85 | 7.07 | 13.15 |
| Debt to equity ratio | 0.44 | 0.47 | 0.57 | 0.40 | 0.22 | 0.50 | 0.42 | 0.43 | 0.34 | 0.26 | 0.23 | 0.29 | 0.28 | 0.09 | 0.05 | 0.03 | 0.02 | 0.01 | 0.07 | 0.05 |
| Return on equity % | 0 | 13.06 | 14.20 | 20.26 | 24.12 | 21.56 | 17.50 | 17.42 | 19.79 | 17.02 | 11.68 | 11.55 | 9.11 | 11.93 | 17.05 | 0.86 | 19.60 | 24.44 | 28.92 | 29.97 |
Indraprastha Medical Corporation Ltd Price to Sales Ratio
The Indraprastha Medical Corporation Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Indraprastha Medical Corporation Ltd's valuation, profitability, and overall financial performance. Tracking the Indraprastha Medical Corporation Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Indraprastha Medical Corporation Ltd (NSE: INDRAMEDCO, BSE: 532150) is currently trading at ₹382.95, with a market capitalization of ₹3506.95Cr. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Indraprastha Medical Corporation Ltd Price to Sales Ratio is essential for fundamental analysis.
Indraprastha Medical Corporation Ltd Price to Sales Ratio Current Value
The current Indraprastha Medical Corporation Ltd Price to Sales Ratio stands at 2.61.
The latest Indraprastha Medical Corporation Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Indraprastha Medical Corporation Ltd Price to Sales Ratio Historical Trend
The Indraprastha Medical Corporation Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 2.61
- 2023: 1.26
- 2022: 0.65
- 2021: 0.60
- 2020: 0.80
The recent rise in Indraprastha Medical Corporation Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.
What Indraprastha Medical Corporation Ltd Price to Sales Ratio Indicates for Investors
The Indraprastha Medical Corporation Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Indraprastha Medical Corporation Ltd Price to Sales Ratio Analysis Summary
The Indraprastha Medical Corporation Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Indraprastha Medical Corporation Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Indraprastha Medical Corporation Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.